Maastricht University Medical Center
Maastricht, Netherlands
NCT Number: NCT03236259
The purpose of this study is to investigate the effects of daily supplementation of Brainport for a period of 6 months on cognitive health.
Looking for future studies?
Notify Me40 year–60 year
All sexes
Interventional
Not applicable
Maastricht, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
berry extract, high dose. Daily ingestion of capsule
Berry extract, low dose. Daily ingestion of capsule
Maltodextrin. Daily ingestion of capsule
Time frame: 6 months
test attention with STROOP
Time frame: 6 months
Test concentration with 'cijferdoorstreep test'
Time frame: 6 months
Test psychomotor speed with grooved pegboard
Time frame: 6 months
measure vascular structure with ultrasound.
Time frame: 6 months
Test mood with visual analogue mood scale. 8 emotions are scored on a 1-10 scale.
Time frame: 6 months
Time frame: 6 months
analysis of alkaline phosphatase, alanine aminotransferase, aspartaat aminotransferase, bilirubine, gamma-glutamyltransferase to determine liver function.
Time frame: 6 months
monoamine oxidase B analysis
Maastricht University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03884647
Alzheimer Disease, Arrhythmias, Cardiac
Walnut Creek, California, United States
View Trial DetailsNCT07152483
Body Weight, Cognition Disorders
Hangzhou, Zhejiang, China
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT04907565
Body Weight, Cognition Disorders
Toulouse, France
View Trial Details